CA
NZ
UK
AU
IND
US
In an unusual display of transparency, Darren Woods, CEO of ExxonMobil (NYSE: XOM), recently addressed the volatile landscape of oil pricing. While he refrained from forecasting exact price levels, Woods revealed that ExxonMobil’s financial strategies are robust enough to withstand scenarios where oil prices …
Altimmune (Nasdaq: ALT) is positioning itself in a competitive landscape with its development of pemvidutide, a GLP-1/glucagon dual agonist. Early data from Phase 2 trials suggest that pemvidutide can achieve weight loss exceeding 15% over 48 weeks, with a notable reduction in muscle loss …
Ron Baron, the astute growth investor renowned for his substantial returns on Tesla, has put forth a startling projection for SpaceX: a valuation of $30 trillion. This figure, equivalent to the combined market capitalisations of Apple, Microsoft, NVIDIA, and Google, is not mere hyperbole. …
ExxonMobil (NYSE: XOM) presents an intriguingInvestmentcase, particularly at a time when oil prices hover around $120 per barrel. A detailed sum-of-parts analysis reveals that Exxon’s operations, spanning the lucrative Permian Basin, deepwater projects in Guyana, and integration synergies from itsAcquisitionof Pioneer Natural Resources, collectivelyYieldan …
Cathie Wood's ARK Invest has generated considerable buzz with its $2,600 price target for Tesla (Nasdaq: TSLA), predicated on the potential of a robotaxi network. This target includes a significant $75 per share derived from expected revenues generated by 1.5 million robotaxis, each running …
Apple Inc. (Nasdaq: AAPL) has long been criticized for its seemingly cautious approach to artificial intelligence, especially when compared to the rapid advancements of competitors like Google and Microsoft. However, this "slow and steady" strategy is beginning to reveal its merit. Central to Apple's …
The landscape of fixed-income investment is rapidly shifting, with traditional avenues likeGovernment Bondsand corporateDebtyieldingDiminishing Returns. In this context, Business Development Companies (BDCs) have emerged as attractive alternatives. ETFs such as PBDC and BIZD focus on private credit, a sector that has quietly ballooned to …
Goldman Sachs' endorsement of Abbott Laboratories hinges on the impressive trajectory of its FreeStyle Libre continuous glucose monitoring (CGM) franchise. With annual revenues exceeding $6 billion and a growth rate surpassing 20%, thisBusinesssegment represents a formidable growth engine amid large-cap healthcare companies. The expansion …
Costco (Nasdaq: COST) has adopted a counterintuitive pricing strategy that emphasizes lowering prices on essential, high-frequency items such as rotisserie chicken, hot dogs, and gasoline. This tactic, while raising prices on discretionary products, has fostered an impressive 93% member renewal rate. The company’sBusinessmodel hinges …
In the evolving landscape of dividend stocks, those that demonstrate defensive revenue characteristics are increasingly sought after. As of June 2026, companies in sectors such as utilities, healthcare, and consumer staples have shown resilience against economic fluctuations. This defensive positioning not only provides stability …
Please wait processing your request...